* Sanara Medtech Inc SMTI.OQ SMTI.O is expected to show
a rise
in quarterly revenue when it reports results on March 20.
* The Fort Worth Texas-based company is expected to report
a
110.4% increase in revenue to $14.8 million from $7.03 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Sanara Medtech Inc
is for
a loss of 26 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $60, above its last closing price of $40.79.
This summary was machine generated March 17 at 20:49 GMT. All
figures in US dollars unless otherwise stated